Skip to main content
SpringerLink
Log in

Toward a Safer Blood Supply: The Impact of Molecular Testing

  • Chapter
  • First Online:
Molecular Diagnostics

Part of the book series: Molecular and Translational Medicine ((MOLEMED))

  • 2145 Accesses

Abstract

Blood banks in the USA strive to have the safest blood supply in the world. To accomplish this, testing for infectious diseases is federally mandated through strict regulatory measures and is continuously monitored for effectiveness and accuracy. Extraordinary quality assurance oversight is omnipresent and monitored by several government and nongovernmental organizations including the Food and Drug Administration (FDA), American Association of Blood Banks (AABB), and various state health authorities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Facts about the blood supply. http://www.redcrossblood.org/learn-about-blood/blood-facts-and-statistics. Retrieved 27 July 2012.

  2. Weusten JJ, van Drimmelen HA, Lelie PN. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT. Transfusion. 2002;42(5):537–48.

    Article  PubMed  Google Scholar 

  3. Constantine NT, Saville RD, Dax EM. Retroviral testing and quality assurance: essentials for laboratory diagnosis. Ann Arbor, MI: Malloy Printers; 2005.

    Google Scholar 

  4. Branson BM, McDougal JS. Establishing the diagnosis of HIV infection. In: Dolin R, Masur H, Saag M, editors. AIDS therapy. 3rd ed. Philadelphia, PA: Churchill-Livingstone and Elsevier Inc.; 2008. p. 1–22.

    Google Scholar 

  5. Barletta JM, Edelman DC, Constantine NT. Lowering the detection limits of HIV-1 viral load using real-time immuno-PCR for HIV-1 p24 antigen. Am J Clin Pathol. 2004;122:20–7.

    Article  PubMed  CAS  Google Scholar 

  6. Barletta J, Bartolome A, Constantine NT. Immunomagnetic quantitative immuno-PCR for detection of less than one HIV-1 virion. J Virol Methods. 2009;157:122–32.

    Article  PubMed  CAS  Google Scholar 

  7. Wainberg MA, Brenner BG. The impact of HIV genetic polymorphisms and subtype differences on the occurrence of resistance to antiretroviral drugs. Mol Biol Int. 2012;2012:256982.

    PubMed  Google Scholar 

  8. Alter HJ, Klein HG. The hazards of blood Transfusion in historical perspective. Blood. 2008;112(7): 2617–26.

    Article  PubMed  CAS  Google Scholar 

  9. Rao MR, Abdollah B, Naficy AB, Darwish MA, Darwis NM, Schisterman E, Clemens JD, Edelman R. Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt. BMC Infect Dis. 2002;2:29–34.

    Article  PubMed  CAS  Google Scholar 

  10. Chou R, Clark E, Helfand M. Screening for hepatitis C virus infection [Internet]. Rockville, MD: Agency for Healthcare Research and Quality (US); 2004. Systematic Evidence Reviews, No. 24. http://www.ncbi.nlm.nih.gov/books/NBK43248/.

    Google Scholar 

  11. Ribeiro MA, Martins ML, Teixeira C, Ladeira R, de Fátima OM, Januário JN, Proietti FA, Carneiro-Proietti AB. Blocking vertical transmission of human T-cell lymphotropic virus type 1 and 2 through breastfeeding interruption. Pediatr Infect Dis J. 2012;31(11):1139–43.

    Article  PubMed  Google Scholar 

  12. Blood safety: reducing the risk of transfusion-transmitted infections. http://www.unboundmedicine.com/redbook/ub/view/RedBook/187182/3/blood_safety:_reducing_the_risk_of_transfusion_transmitted_infections. Accessed 4 Aug 2012.

  13. Roback JD, Combs MR, Grossman BJ, Hillyer CD, editors. Technical manual. 16th ed. Bethesda, MD: American Association of Blood Banks; 2008.

    Google Scholar 

  14. Rassi Jr A, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010 April 17;375(9723):1388–402. Review.

    Google Scholar 

  15. Young C, Losikoff P, Chawla A, Glasser L, Forman E. Transfusion-acquired Trypanosoma cruzi infection. Transfusion. 2007 Mar;47(3):540–4.

    Google Scholar 

  16. Mascola L, Kubak B, Radhakrishna S, Mone T, Huntere R, Leiby DA, Kuehnert M, Moore A, Steurer F, Lawrence G, Kun H. Chagas disease after organ transplantation – Los Angeles, CA, 2006. MMWR Morb Mortal Wkly Rep. 2006;55:798–800.

    Google Scholar 

  17. Kun H, Moore A, Mascola L, Steurer F, Lawrence G, Kubak B, Radhakrishna S, Leiby D, Herron R, Mone T, Hunter R, Kuehnert M. Chagas disease in transplant recipients investigation team. Clin Infect Dis. 2009 Jun 1;48(11):1534–40.

    Google Scholar 

  18. Teizeira AR, Hecht MM, Guimaro MC, Sousa AO, Nitz N. Pathogenesis of chagas’ disease: parasite persistence and autoimmunity. Clin Microbiol Rev. 2011 Jul;24(3):592–630. Review.

    Google Scholar 

  19. Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis. 2009 Sep 1;49(5):52–4.

    Google Scholar 

  20. Galavíz-Silva L, Molina-Garza DP, González-Santos MA, Mercado-Hernández R, González-Galavíz JR, Rosales-Encina JL, Molina-Garza ZJ. Update on seroprevalence of anti-Trypanosoma cruzi antibodies among blood donors in northeast Mexico. Am J Trop Med Hyg. 2009 Sep;81(3):404–6.

    Google Scholar 

  21. Blumberg BS, Alter HJ, Visnich S. A “new” antigen in leukemia sera. JAMA. 1965;191:541.

    Article  PubMed  CAS  Google Scholar 

  22. MMWR. Public health service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence. MMWR Recomm Rep. 1991;40(RR-4):1–17.

    Google Scholar 

  23. Zou S, Notari EP, Musavi F, Dodd RY, ARCNET Study Group. Current impact of the confidential unit exclusion option. Transfusion. 2004 May;44(5):651–7.

    Google Scholar 

  24. Stramer S. Current risks of transfusion-transmitted agents – a review. Arch Pathol Lab Med. 2007;131:702–7.

    PubMed  Google Scholar 

  25. Zou S, Dorsey K, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY, Stramer S. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion. 2010;50:1495–504.

    Article  PubMed  Google Scholar 

  26. Stramer SL, Wend U, Candotti D, Foster GA, Hollinger FB, Dodd RY, Allain JP, Gerlich W. Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med. 2011;364:236–47.

    Article  PubMed  CAS  Google Scholar 

  27. Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Transfusion. 2012;52:440–6.

    Article  PubMed  CAS  Google Scholar 

  28. Infectious disease testing. http://www.redcrossblood.org/hospitals/infectious-disease-testing Accessed 26 July 2012.

  29. Proietti FA, Carneiro-Proietti ABF, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24:6058–68.

    Article  PubMed  CAS  Google Scholar 

  30. Kaidarova Z, Murphy EL. HTLV-I and –II seroprevalence among United States blood donors, 2000–2009. Retrovirology. 2011;8 suppl 1:A74.

    Article  Google Scholar 

  31. Montgomery S, Brown J, Kushneri M, Smith TL, Crall N, Lanciotti S, Macedo de Oliveira A, Boo T, Marfin AA, 2003 West Nile Virus Transfusion-associated Transmission Investigation Team. Transfusion-associated transmission of West Nile Virus, United States 2003 through 2005. Transfusion. 2006;46(12):2038–46.

    Article  PubMed  Google Scholar 

  32. Custer B, Agapova M, Bruhn R, Cusick R, Kamel H, Tomasulo P, Biswas H, Tobler L, Lee TH, Caglioti S, Busch M. Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi. Transfusion. 2012;52(9):1901–11.

    Article  PubMed  Google Scholar 

  33. Bern C, Montgomery SP, Katz L, Caglioti S, Stramer SL. Chagas disease and the US blood supply. Curr Opin Infect Dis. 2008 Oct;21(5):476–82.

    Google Scholar 

  34. Rosenberg E, Brennan C, Claessens C, Constantine N, Murphy G, Owen S, Werner B, Yao J, Yen-Lieberman B, Branson B, Garrett P, Howell R. Criteria for laboratory testing and diagnosis of HIV infection. CLSI, M53-P, 30(21), ISBN: 1-56238-735-9, 2011.

    Google Scholar 

  35. Hare, CB, Pappalardo, BL, Busch MP, Phelps B, Alexander SS, Ramstead C, Levy JA, Hecht, FM. Negative antibody test results among individuals treated with antiretroviral therapy (ART) during acute/early infection. International AIDS Society Meeting, Bangkok, Thailand, 11–16 July, 2004. Poster MoPeB3107.

    Google Scholar 

  36. Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS. 2003;17:1871.

    Article  PubMed  Google Scholar 

  37. Lindback S, Thorstensson R, Karlsson AC, et al. Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. AIDS. 2000;14:2333.

    Article  PubMed  CAS  Google Scholar 

  38. Petersen LR, Satten GA, Dodd R, Busch M, Kleinman S, Grindon A, Lenes B. Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody. The HIV Seroconversion Study Group. Transfusion. 1994 Apr;34(4):283–9.

    Google Scholar 

  39. Lu SN, Tung HD, Chen TM, Lee CM, Wang JH, Hung CH, Chen CH, Changchien CS. Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titre rather than by seroconversion? J Viral Hepat. 2004 Nov;11(6):563–70.

    Google Scholar 

  40. FDA website. http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/ucm077899.htm.

  41. Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY. West Nile Virus among blood donors in the United States, 2003 and 2004. N Engl J Med. 2005;353:451–9.

    Article  PubMed  CAS  Google Scholar 

  42. Busch MP, Caglioti S, Robertson EF, McAuley JD, Tobler LH, Kamel H, Linnen JM, Shyamala V, Tomasulo P, Kleinman SH. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med. 2005;353:460–7.

    Article  PubMed  CAS  Google Scholar 

  43. Kleinman SH, Williams JD, Robertson G, Caglioti S, Williams RC, Spizman R, Morgan L, Tomasulo P, Busch MP. West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual-donation nucleic acid testing. Transfusion. 2009;49:1160–70.

    Article  PubMed  Google Scholar 

  44. Francis RO, Strauss D, Williams JD, Whaley S, Shaz BH. West Nile Virus infection in blood donors in the New York City area during the 2010 seasonal epidemic. Transfusion. 2012;52(12):2664–70. doi:10.1111/j.1537-2995.2012.03639.x.

    Article  PubMed  Google Scholar 

  45. PROCLEIX package insert from FDA approval site. http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM090247.p.

  46. cobas® TaqScreen WNV Test labeling package insert from FDA approval site. http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM091938.p.

  47. PROCLEIX HIV-1/HCV package insert from FDA approval site. http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/ucm092022.htm.

  48. PROCLEIX ULTRIO PLUS Assay package insert from FDA approval site. http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/ucm080466.htm.

  49. COBAS TaqScreen MPX Test package insert from FDA approval site. http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/UCM176443.

  50. Engel M. Making the blood supply safe also makes it more expensive. Los Angeles Times. 2007. Retrieved 27 July 2012. http://articles.latimes.com/2007/sep/02/local/me-bloodside2.

  51. Rauber C, Robertson K. Rising price of blood puts squeeze on hospitals. San Francisco Business Times. 2007. Retrieved 27 Mar 2012. http://www.bizjournals.com/sanfrancisco/stories/2007/01/29/story14.html.

  52. Toner RW, Pizzi L, Leas B, Ballas SK, Quigley A, Goldfarb NI. Costs to hospitals of acquiring and processing blood in the US: a survey of hospital-based blood banks and transfusion services. Appl Health Econ Health Policy. 2011;9(1):29–37.

    Article  PubMed  Google Scholar 

  53. Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion. April 2010;50:753–65.

    Google Scholar 

  54. Custer B. The cost of blood: did you pay too much or did you get a good deal? Transfusion. April 2010;50:742–4.

    Google Scholar 

  55. Testimony on FDA’s regulation of blood, blood products, and plasma by Michael A. Friedman, M.D., FDA Lead Deputy Commissioner, before the House Committee on Government Reform and Oversight, Subcommittee on Human Resources and Intergovernmental Relations, June 5, 1997. http://www.hhs.gov/asl/testify/t970605a.html.

  56. American Association of Blood Banks. Standards for blood banks and transfusion services. 27th ed. Bethesda, MD: AABB; 2011.

    Google Scholar 

  57. Roback JD, editor. Technical manual. 17th ed. Bethesda, MD: AABB; 2011.

    Google Scholar 

  58. Constantine NT, Zhao RY. Molecular-based laboratory testing and monitoring for human immunodeficiency virus infections. Clin Lab Sci. 2005;18(4):263–70.

    PubMed  Google Scholar 

  59. Sanjai Kumar, Academy of Science meeting, ref: Nature Med., 19, 2011.

    Google Scholar 

  60. Landro L. New threats to U.S. blood supply. http://online.wsj.com/article/SB10001424052748704792104575264600619273586.html. Accessed 31 July 2012.

  61. Stramer S. Reported at meeting of Academy of Science, ref-Nature Med, 17, 2011.

    Google Scholar 

  62. Keeping the U.S. blood supply safe. p. 14–16. http://www.mlo-online.com/features/2010_july/0710_10.pdf.

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA

    Niel T. Constantine Ph.D., M.T. (A.S.C.P.) & Ahmed Saleh Ph.D.

  2. Signature Healthcare-Brockton Hospital, Brockton, MA, USA

    Patricia A. Wright B.A., M.T.(A.S.C.P.)S.B.B.

  3. Faculty of Science, Zoology Department, Cairo University, Cairo, Egypt

    Ahmed Saleh Ph.D.

  4. The DeMarinis Group, LLC, North Attleborough, MA, USA

    Anna DeMarinis M.A., M.T.(A.S.C.P.)S.B.B., C.Q.A.(A.S.Q.)

Authors
  1. Niel T. Constantine Ph.D., M.T. (A.S.C.P.)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patricia A. Wright B.A., M.T.(A.S.C.P.)S.B.B.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ahmed Saleh Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anna DeMarinis M.A., M.T.(A.S.C.P.)S.B.B., C.Q.A.(A.S.Q.)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Niel T. Constantine Ph.D., M.T. (A.S.C.P.) .

Editor information

Editors and Affiliations

  1. Medicine and Pathology Molecular Genetics Laboratory, Mayo Clinic College of Medicine Department of Laboratory, Rochester, Minnesota, USA

    W. Edward Highsmith, Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Constantine, N.T., Wright, P.A., Saleh, A., DeMarinis, A. (2014). Toward a Safer Blood Supply: The Impact of Molecular Testing. In: Highsmith, Jr., W. (eds) Molecular Diagnostics. Molecular and Translational Medicine. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4614-8127-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8127-0_8

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4614-8126-3

  • Online ISBN: 978-1-4614-8127-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation